Investigating how a budget program affects costs and care quality for cancer patients receiving chemotherapy
Official title: Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
Funded at Sloan-Kettering Inst Can Research · NIH-10928787 · Data updated 2026-11-12
This study looks at how a new budget program affects cancer patients getting chemotherapy, focusing on whether it changes the costs and quality of their care, especially for those who might have a harder time accessing treatments.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 13, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $494,244 |
| NIH project number | 5R37CA276322-02 |
| Project ID | NIH-10928787 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients undergoing chemotherapy, particularly those from racial minority groups or with socioeconomic vulnerabilities.
✕Less likely to help
Patients who are not undergoing chemotherapy or those with non-cancer-related health issues may not benefit from this research.
What this research studies
This research examines the impact of the Global Budget Revenue (GBR) program on cancer patients undergoing chemotherapy. It aims to understand how this budget model influences healthcare costs and the quality of care provided, particularly focusing on potential disparities in access to effective treatments for vulnerable populations. By analyzing data through a difference-in-differences approach, the study seeks to identify both positive and negative outcomes associated with the GBR program, especially regarding its effects on cancer care equity. The findings could inform future healthcare policies and practices.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare policies that enhance access to quality cancer treatment for all patients.
How similar studies have gone: Previous evaluations of similar budget models have shown mixed results, indicating both potential savings and concerns regarding access to care, making this research particularly relevant.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Offodile, Anaeze C — Sloan-Kettering Inst Can Research
- Study coordinator: Offodile, Anaeze C
Related research
Other NIH-funded projects on the same topics.
-
Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer
A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.
-
Dual targeting of heart cell receptors to prevent chemotherapy heart damage
Atrial patients receiving the chemotherapy drug doxorubicin may be protected from heart damage by targeting two heart cell receptors at once.
-
A 3D ultrasound scanner to see early chemotherapy response in breast cancer
A new 3D ultrasound imaging method will be tested to see if it can quickly show whether breast cancer is responding to chemotherapy.
-
Non-invasive, microscopic biomarkers to detect CIPN in chemotherapy patients
This grant aims to develop a non-invasive imaging method to measure nerve changes in patients undergoing chemotherapy to better understand and monitor chemotherapy-induced peripheral neuropathy (CIPN).
-
Alternative NF-kB activation after chemotherapy in ovarian cancer
This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.
-
Genetic clues for doxorubicin heart risk using patient-derived heart cells
A research project tests how human heart cells grown from stem cells react to a common chemotherapy to see which genetic differences may raise the risk of heart damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.